219 related articles for article (PubMed ID: 1603491)
21. Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study.
Cramer DW
Obstet Gynecol; 1999 Jul; 94(1):160-1. PubMed ID: 10389743
[No Abstract] [Full Text] [Related]
22. Perineal powder exposure and the risk of ovarian cancer.
Cook LS; Kamb ML; Weiss NS
Am J Epidemiol; 1997 Mar; 145(5):459-65. PubMed ID: 9048520
[TBL] [Abstract][Full Text] [Related]
23. Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer.
Cramer DW; Titus-Ernstoff L; McKolanis JR; Welch WR; Vitonis AF; Berkowitz RS; Finn OJ
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1125-31. PubMed ID: 15894662
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
25. Estrogen replacement therapy and ovarian cancer.
Folsom AR; Anderson JP; Ross JA
Epidemiology; 2004 Jan; 15(1):100-4. PubMed ID: 14712153
[TBL] [Abstract][Full Text] [Related]
26. Perineal powder use and risk of ovarian cancer.
Houghton SC; Reeves KW; Hankinson SE; Crawford L; Lane D; Wactawski-Wende J; Thomson CA; Ockene JK; Sturgeon SR
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25214560
[TBL] [Abstract][Full Text] [Related]
27. Oral contraceptives and epithelial ovarian cancer. Does dose matter?
Sanderson M; Williams MA; Weiss NS; Hendrix NW; Chauhan SP
J Reprod Med; 2000 Sep; 45(9):720-6. PubMed ID: 11027080
[TBL] [Abstract][Full Text] [Related]
28. Presence of talc in pelvic lymph nodes of a woman with ovarian cancer and long-term genital exposure to cosmetic talc.
Cramer DW; Welch WR; Berkowitz RS; Godleski JJ
Obstet Gynecol; 2007 Aug; 110(2 Pt 2):498-501. PubMed ID: 17666642
[TBL] [Abstract][Full Text] [Related]
29. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk.
Parazzini F; Negri E; La Vecchia C; Luchini L; Mezzopane R
Obstet Gynecol; 1993 Mar; 81(3):363-6. PubMed ID: 8437787
[TBL] [Abstract][Full Text] [Related]
30. Analgesic drug use and risk of epithelial ovarian cancer.
Hannibal CG; Rossing MA; Wicklund KG; Cushing-Haugen KL
Am J Epidemiol; 2008 Jun; 167(12):1430-7. PubMed ID: 18390840
[TBL] [Abstract][Full Text] [Related]
31. Gender of offspring and maternal ovarian cancer risk.
Gierach GL; Modugno F; Ness RB
Gynecol Oncol; 2006 Jun; 101(3):476-80. PubMed ID: 16364411
[TBL] [Abstract][Full Text] [Related]
32. Time since last birth and the risk of ovarian cancer.
Chiaffarino F; Parazzini F; Negri E; Benzi G; Scarfone G; Franceschi S; La Vecchia C
Gynecol Oncol; 2001 May; 81(2):233-6. PubMed ID: 11330955
[TBL] [Abstract][Full Text] [Related]
33. Perineal Talc Use and Ovarian Cancer: A Systematic Review and Meta-Analysis.
Penninkilampi R; Eslick GD
Epidemiology; 2018 Jan; 29(1):41-49. PubMed ID: 28863045
[TBL] [Abstract][Full Text] [Related]
34. Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study.
Wong C; Hempling RE; Piver MS; Natarajan N; Mettlin CJ
Obstet Gynecol; 1999 Mar; 93(3):372-6. PubMed ID: 10074982
[TBL] [Abstract][Full Text] [Related]
35. Genital talc exposure and risk of ovarian cancer.
Cramer DW; Liberman RF; Titus-Ernstoff L; Welch WR; Greenberg ER; Baron JA; Harlow BL
Int J Cancer; 1999 May; 81(3):351-6. PubMed ID: 10209948
[TBL] [Abstract][Full Text] [Related]
36. Perineal application of talc and cornstarch powders: evaluation of ovarian cancer risk.
Whysner J; Mohan M
Am J Obstet Gynecol; 2000 Mar; 182(3):720-4. PubMed ID: 10739536
[TBL] [Abstract][Full Text] [Related]
37. Body size and risk of epithelial ovarian cancer (United States).
Rossing MA; Tang MT; Flagg EW; Weiss LK; Wicklund KG; Weiss NS
Cancer Causes Control; 2006 Jun; 17(5):713-20. PubMed ID: 16633919
[TBL] [Abstract][Full Text] [Related]
38. Pelvic inflammatory disease and risk of ovarian cancer.
Parazzini F; La Vecchia C; Negri E; Moroni S; dal Pino D; Fedele L
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):667-9. PubMed ID: 8824371
[TBL] [Abstract][Full Text] [Related]
39. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
[TBL] [Abstract][Full Text] [Related]
40. Height, age at menarche, and risk of epithelial ovarian cancer.
Jordan SJ; Webb PM; Green AC
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2045-8. PubMed ID: 16103459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
